Cargando…

Retraction: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432686/ https://www.ncbi.nlm.nih.gov/pubmed/36044431 http://dx.doi.org/10.1371/journal.pone.0273489

Ejemplares similares

Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future: Retraction
Publicado: (2020)

Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2022)

Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19
por: Jin, Changzhong, et al.
Publicado: (2021)

Retraction: The Impact of Charlson Comorbidity Index on Mortality From SARS-CoV-2 Virus Infection
por: Ahmed, Jawad, et al.
Publicado: (2022)

Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study
por: Obesity, Journal of
Publicado: (2022)

Retracted: Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins
por: and Applications, Bioinorganic Chemistry
Publicado: (2023)

Retraction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mimicking as Pulmonary Tuberculosis in an Inmate
por: Akbar, Hina, et al.
Publicado: (2021)

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
por: Abbott, Timothy R., et al.
Publicado: (2020)

Potential antiviral peptides against the nucleoprotein of SARS-CoV-2
por: Mahdi, Iktedar, et al.
Publicado: (2022)

Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2
por: Sung, Johnny Chun-Chau, et al.
Publicado: (2022)

Potential antiviral peptides targeting the SARS-CoV-2 spike protein
por: Khater, Ibrahim, et al.
Publicado: (2022)

Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
por: Zhang, Luoping, et al.
Publicado: (2020)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
por: Wang, Xinling, et al.
Publicado: (2020)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

Retraction: Jiang, H.; Mei, Y.-F. SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses 2021, 13, 2056
por: Jiang, Hui, et al.
Publicado: (2022)

Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation [Retraction]
Publicado: (2022)

RETRACTED: Agrawal et al. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022, 27, 3828
por: Agrawal, Pawan K., et al.
Publicado: (2023)

Photodynamic Inactivation of SARS-CoV-2 Infectivity and Antiviral Treatment Effects In Vitro
por: Ziganshyna, Svitlana, et al.
Publicado: (2022)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
por: Hussein, Mouraya, et al.
Publicado: (2023)

Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection
por: Maiti, Biplab K.
Publicado: (2020)

Retracted papers on SARS-CoV-2 and COVID-19
por: Cortegiani, Andrea, et al.
Publicado: (2021)

Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2
por: Khan, Mohammad Mansoob, et al.
Publicado: (2022)

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
por: Zhou, Hong, et al.
Publicado: (2020)

A review on the potential of photocatalysis in combatting SARS-CoV-2 in wastewater
por: Nasir, Atikah Mohd, et al.
Publicado: (2021)

SARS-CoV-2: Combating Coronavirus Emergence
por: Graham, Rachel L., et al.
Publicado: (2020)

Retraction: Samaha et al. Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon. Viruses 2021, 13, 989
por: Samaha, Ali A., et al.
Publicado: (2021)

Retraction: Effects of the COVID-19 Pandemic on Stroke Patients
por: Ghanchi, Hammad, et al.
Publicado: (2021)

Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2
por: Sumon, Tofael Ahmed, et al.
Publicado: (2021)

Retraction: Inactivation of MAP kinase signalling in Myc Transformed Cells and Rescue by LiCl inhibition of GSK3
por: Al-Assar, Osama, et al.
Publicado: (2005)

Retracted: CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR
por: Healthcare Engineering, Journal of
Publicado: (2023)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
por: Johansen-Leete, Jason, et al.
Publicado: (2022)

Retraction: Non-specific Immune Response of Rainbow Trout (Oncorhynchus Mykiss) by Dietary Heat-inactivated Potential Probiotics. Immune Network 2008;8(3):67-74.
por: Choi, Sang-Hoon, et al.
Publicado: (2011)

TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
por: Ansari, Mohammad Azam, et al.
Publicado: (2020)

Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases
por: Homaeigohar, Shahin, et al.
Publicado: (2023)

Retraction: screening and identification of a renal carcinoma specific peptide from a phage display peptide library
por: Tu, Xiangan, et al.
Publicado: (2012)

Retraction: Fingolimod inhibits proliferation and epithelial- mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signaling
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t1k7nra0lmqc569a3n2opiph6c